Union Product Database

The Union Product Database (UPD) serves as a single source of information on all authorised veterinary medicines and their availability in European Union (EU) and European Economic Area (EEA) Member States. The European Medicines Agency (EMA) set up and maintains the veterinary medicines information website and the Union Product Database, in collaboration with the Member States and the European Commission.
Veterinary

Updated on 11 September 2025:
Content revised to reflect up-to-date information

The Union Product Database (UPD) contains information on:

  • all authorised veterinary medicinal products,
  • homeopathic veterinary medicinal products,
  • veterinary medicinal products intended for animals which are exclusively kept as pets in the EU/EEA: aquarium or pond animals, ornamental fish, cage birds, homing pigeons, terrarium animals, small rodents, ferrets and rabbits.

The UPD was launched in January 2022. It was established by the Veterinary Medicines Regulation (Regulation (EU) 2019/6). 

For more information, see Veterinary Medicinal Products Regulation.

Registration and access to UPD restricted area

The restricted area of the Union Product Database (UPD) is only accessible to:

  • staff of the European Commission;
  • national competent authorities;
  • marketing authorisation holders.

Registered users can access it via:

  • UPD user interface;
  • UPD application programming interface (API) machine-to-machine connection.

Find below a registration guide with step-by-step instructions on how to request access to the restricted areas of the UPD user interface and API:

The registration guide also contains instructions for marketing authorisation holders on how to request access to the UPD via read-only API.

Detailed guidance and technical specifications for all API users can be found in Chapter 5 of the EU Implementation Guide (referenced in the section below).

System release notes

After each deployment, users can consult the UPD release notes to stay informed about the latest enhancements, fixes, and functional updates.

The Veterinary Medicines information website is the public interface of the UPD.

Available in 26 different languages, this access-free website enables everyone to:

  • search and view information on all authorised veterinary medicines in the EU / EEA, registered homeopathics and assorted other pet products;
  • consult product information and public assessment reports;
  • learn in which Member State a specific veterinary medicine is available;
  • find information which could help identify potential treatment alternatives.

Implementation guide

The UPD implementation guide provides instructions to national competent authorities and marketing authorisation holders when submitting veterinary medicines data to the UPD in a standardised format and terminology across the EU.

The different chapters provide guidance on:

  • format for the electronic submission of veterinary medicinal product information (Chapter 2),
  • API technical specifications (Chapter 5),
  • submission of other post-authorisation data (Chapter 7).
     

The UPD uses standardised terminology from the four SPOR data management services for managing master data in the EU. 

For more information, see Substance, product, organisation and referential (SPOR) master data.

Guidance for national competent authorities

Along with the UPD implementation guide, national competent authorities have available dedicated guidance for:

•    configuring and managing system notifications,
•    identifying the VNRA “Decision Maker”,
•    updating packages without altering the product identifier.

Further instructions for other regulatory tasks can be found in the Video tutorials section.

To keep up to date with the latest functionalities release, please consult the System release notes.

For technical support, to report a bug or accessibility issues in Union Product Database, users should open a ticket via EMA Service Now.

For general questions not covered by this guidance, users may send a question to the European Medicines Agency.

Guidance for marketing authorisation holders

Marketing authorisation holders should submit the following to the Union Product Database:

  • Variations not requiring assessment (VNRA);
  • Volume of sales (VoS);
  • Availability status of the product;
  • Changes to the authorisation status.

Update: The deadline for submitting the volume of sales data in 2025 is 28 February 2026.

Along with Chapter 7 of the UPD implementation guide, marketing authorisation holders have available dedicated guidance for:

•    frequently asked questions,
•    configuring and managing system notifications,
•    calculating the dose factor for each veterinary medicinal product.

Further instructions for other regulatory tasks can be found in the Video tutorials section.

To keep up to date with the latest functionalities release, please consult the System release notes.

For technical support, to report a bug or accessibility issues in Union Product Database, users should open a ticket via EMA Service Now.

For general questions not covered by this guidance, users may send a question to the European Medicines Agency.
 

Video tutorials

Webinars and training activities

EMA organises webinars and training activities regulary. This is to support national competent authorities and marketing authorisation holders in the different regulatory processes in UPD. 

National competent authorities can access the relevant training materials and webinar recordings via the EU Network Training Center Portal.

Veterinary industry users can consult the recordings and associated materials below:

What to do in case of system failure

Organisations should make sure that adequate business continuity processes and back-up systems are in place to deal with system failures. This will ensure that any system failures can be resolved within a short period of time and submissions made in a timely manner.

In case of a system failure of the Union Product Database requiring resolution by EMA, the organisation will be considered compliant with any submission deadlines if they submit as soon as possible after the Union Product Database becomes available again.

For example, marketing authorisation holders have 30 days after implementing a relevant change to submit a variation not requiring assessment into the Union Product Database. Should the system not be accessible on the day an organisation wishes to submit a variation not requiring assessment, they should submit within 2 business days after the system becomes available again.

If you require technical support, wish to report a bug or are experiencing accessibility issues in Union Product Database, please open a ticket via EMA Service Now.

Access policy

The access policy for the Union Product Database sets out the types of information different user groups will be allowed to access.

Processing of personal data

joint controllership arrangement describes the processing of personal data in the Union Product Database, in accordance with the General Data Protection Regulation and EU Data Protection Regulation. 

The joint controllership arrangement describes the roles and responsibilities of EMA and the Member States regarding the processing of personal data in the database. It sets out the measures they must put in place to ensure that personal data in the database is securely processed, and covers how the parties are to handle any personal data breaches.

Share this page